10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 272 filers reported holding 10X GENOMICS INC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $588,665 | +13.2% | 10,542 | +13.1% | 0.00% | 0.0% |
| Q1 2023 | $519,851 | +152797.4% | 9,318 | 0.0% | 0.00% | – |
| Q4 2022 | $340 | -100.0% | 9,318 | -95.6% | 0.00% | -100.0% |
| Q2 2022 | $9,484,000 | -45.7% | 209,595 | -8.8% | 0.01% | -35.0% |
| Q1 2022 | $17,476,000 | -55.8% | 229,736 | -13.4% | 0.02% | -48.7% |
| Q4 2021 | $39,506,000 | +96.9% | 265,215 | +92.5% | 0.04% | +77.3% |
| Q3 2021 | $20,060,000 | – | 137,793 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |